[1]王道坤.中医辨证应用毒性药物的安全性探讨[J].西部中医药,2022,35(06):44-47.[doi:10.12174/j.issn.2096-9600.2022.06.12]
　WANG Daokun.The Safety of Toxic Drugs in TCM Syndrome Differentiation[J].Western Journal of Traditional Chinese Medicine,2022,35(06):44-47.[doi:10.12174/j.issn.2096-9600.2022.06.12]
点击复制

中医辨证应用毒性药物的安全性探讨
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
35
期数:
2022年06期
页码:
44-47
栏目:
学术观点
出版日期:
2022-06-15

文章信息/Info

Title:
The Safety of Toxic Drugs in TCM Syndrome Differentiation
作者:
王道坤
甘肃中医药大学，甘肃 兰州 730030
Author(s):
WANG Daokun
Gansu University of Chinese Medicine, Lanzhou 730030, China
关键词:
中药安全性; 辨证用药; 配伍; 炮制; 名老中医
Keywords:
the safety of traditional Chinese medicine; syndrome differentiation and medication; compatibility of medicines; processing; distinguished veteran doctors of TCM
分类号:
R229
DOI:
10.12174/j.issn.2096-9600.2022.06.12
文献标志码:
A
摘要:
结合临床经验，从临床应用十枣汤、大剂量附子及长期服用中成药、怎样预防中药不良反应等方面对临床应用中药的安全性进行了探讨。
Abstract:
Combined with clinical experience, the safety of clinical application of materia medica was discussed from clinical application of Shizao decoction, large dose of Fuzi (Radix Aconiti Lateralis Preparata), long-term use of Chinese patent medicine and how to prevent the adverse reactions of herbs.

备注/Memo

备注/Memo:
王道坤（1941—），男，主任医师，教授，博士研究生导师。研究方向：敦煌医学以及脾胃病研究。
更新日期/Last Update: 2022-06-24